Scottsdale, ARIZONA3 Active Studies

Parkinsons Disease Clinical Trials in Scottsdale, ARIZONA

Find 3 actively recruiting parkinsons disease clinical trials in Scottsdale, ARIZONA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
702
Enrolling

Recruiting Parkinsons Disease Studies in Scottsdale

About Parkinsons Disease Clinical Trials in Scottsdale

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 3 parkinsons disease clinical trials recruiting participants in Scottsdale, ARIZONA. These studies are seeking a combined 702 participants. Research is being sponsored by Biohaven Therapeutics Ltd., Intra-Cellular Therapies, Inc., Prevail Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Scottsdale — FAQ

Are there parkinsons disease clinical trials in Scottsdale?

Yes, there are 3 parkinsons disease clinical trials currently recruiting in Scottsdale, ARIZONA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Scottsdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you about next steps.

Are clinical trials in Scottsdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Scottsdale studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 3 active trials in Scottsdale are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated March 2, 2026 from ClinicalTrials.gov